Search earnings tickers

BMY

2024Q1BMO

Bristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-04-25 · Fiscal end 2024-03-31 · Features as of 2024-04-24

← Earnings history

Street

Consensus EPS-4.14

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.5%

IV front—

P/C full—

P/C front—

Features as of2024-04-24

Run-up

Close—

Ret 5d+2.1%

Ret 10d-2.8%

Ret 20d-7.0%

Ret 30d-10.2%

Print

Actual EPS

-4.40Miss

Estimated EPS-4.14

Actual revenue

11.9B

Surprise %-6.3%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction-5.7%

Implied vs actual

Implied 1.5%Actual 3.0%

Gap reaction-3.0%

Day result-8.5%

Next-day upNo

Realized / IV2.07×

Post tape

Post 5d-2.2%

Post 10d+0.1%

Post volume45.1M

Vol ×10d3.95×

Vol ×20d4.02×

Post range6.6%

BMY

Pre-Earnings Data